About the event
On Tuesday, September 24, 2024, Piramal Pharma Limited hosted its Investor Day, providing comprehensive insights into its business verticals, strategic objectives and long-term vision.
The event commenced with a holistic overview of the Company and its strategic priorities by Ms. Nandini Piramal and Mr. Peter DeYoung. This was followed by detailed presentations by senior management team on the three business verticals - CDMO, Complex Hospital Generics and India Consumer Healthcare. The event concluded with an engaging Q&A session with the leadership team.
Additionally, the event showcased of some of the fast growing power brands from the India Consumer Healthcare portfolio, allowing attendees to experience the best-in-class products first-hand.
Over 250 investors and analysts attended the event.
Management Attendees
Central Partner Function
- Nandini Piramal - Chairperson
- Peter DeYoung - CEO, Global Pharma
- Vivek Valsaraj - Executive Director and Chief Financial Officer
- Viral Gandhi - President & Group Chief Information Officer
- Jatin Lal - President - Mergers & Acquisitions
- Puneet Rajput - Chief Human Resource Officer
- Rashida Najmi - Chief Quality Officer
- Sandeep Rathod - Senior Vice President, Legal
- Radhakrishna B - Associate Vice President - Strategy
- Gagan Borana - Associate Vice President - Investor Relations and Enterprise Risk Management
CDMO
- Herve Berdou - Chief Operating Officer
- Stuart Needleman - Chief Commercial and Chief Patient Centricity Officer
- Chris Leahy - Senior Vice President, Finance
Complex Hospital Generics
- Jeffrey Hampton - President & Chief Operating Officer
- Mahesh Sane - Senior Vice President, Finance
India Consumer Healthcare
- Nitish Bajaj - CEO
- Anagha Deshpande - Vice President, Finance & IT